Zeige Ergebnisse 111 - 120 von 379
2016
Busch, T., Dräger, G., Kunst, E., Benson, H., Sasse, F., Siems, K., & Kirschning, A. (2016). Synthesis and antiproliferative activity of new tonantzitlolone-derived diterpene derivatives. Organic and Biomolecular Chemistry, 14(38), 9040-9045. https://doi.org/10.1039/c6ob01697a
Breznica-Selmani, P., Mladenovska, K., Dräger, G., Mikhova, B., Panovski, N., Kaftandzieva, A., Kavrakovski, Z., Hoxha, A., Sheqerxhiu, N., Pavlova, M. J., & Popovski, E. (2016). Synthesis, physicochemical characterization and antibacterial activity of novel (benzoylamino)methyl derivatives of quinolones. Macedonian Journal of Chemistry and Chemical Engineering, 35(2), 179-197. https://doi.org/10.20450/mjcce.2016.919
Müller, R., & Kirschning, A. (2016). Verbundprojekt: TTU 09.903 - Optimisation of the Cystobactamides, a novel class of broad spectrum antibiotics from myxobacteria: Bereich: DZIF TTU 9 “Neuartige Antiinfektiva”: Schlussbericht. Helmholtz-Zentrum für Infektionsforschung. https://doi.org/10.2314/GBV:876762097
2015
Elmuradov, B., Shakhidoyatov, K., Dräger, G., & Butenschön, H. (2015). Tricyclic quinazoline alkaloids conjugated to ferrocene: Synthesis, structure, and redox behavior of ferrocenylmethylene-substituted 7H-deoxyvasicinones. European Journal of Organic Chemistry, 2016(3), 483-492. https://doi.org/10.1002/ejoc.201501307
Bułyszko, I., Dräger, G., Klenge, A., & Kirschning, A. (2015). Evaluation of the Synthetic Potential of an AHBA Knockout Mutant of the Rifamycin Producer Amycolatopsis mediterranei. Chemistry - A European Journal, 21(52), 19231-19242. https://doi.org/10.1002/chem.201503548
Perin, P. M., Haid, S., Brown, R. J. P., Doerrbecker, J., Schulze, K., Zeilinger, C., von Schaewen, M., Heller, B., Vercauteren, K., Luxenburger, E., Baktash, Y. M., Vondran, F. W. R., Speerstra, S., Awadh, A., Mukhtarov, F., Schang, L. M., Kirschning, A., Müller, R., Guzman, C. A., ... Pietschmann, T. (2015). Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1. Hepatology, 63(1), 49-62. https://doi.org/10.1002/hep.28111
Hartwig, J., & Kirschning, A. (2015). Iterative Syntheses: The Gateway to New Automation Protocols. Angewandte Chemie , 54(36), 10412-10414. https://doi.org/10.1002/anie.201504615, https://doi.org/10.1002/ange.201504615
Müller, R., Hartmann, R. W., Kirschning, A., Weiss, S., Tegge, W., & Häussler, S. (2015). Biofilm-Inhibitoren: Entwicklung von Inhibitoren zur Prävention und Behandlung von Biofilmen humanpathogener Bakterien: Abschlussbericht: Laufzeit des Vorhabens: 01.02.2012-31.01.2015. Twincore Zentrum für Experimentelle und Klinische Infektionsforschung. https://edocs.tib.eu/files/e01fb16/857120247.pdf
Moreno, M., Elgaher, W. A. M., Herrmann, J., Schläger, N., Hamed, M. M., Baumann, S., Müller, R., Hartmann, R. W., & Kirschning, A. (2015). Synthesis and biological evaluation of cystobactamid 507: A bacterial topoisomerase inhibitor from Cystobacter sp. Synlett, 26(9), 1175-1178. Artikel st-2015-b0058-l. https://doi.org/10.1055/s-0034-1380509
Stumpp, N., Premnath, P., Schmidt, T., Ammermann, J., Dräger, G., Reck, M., Jansen, R., Stiesch, M., Wagner-Döbler, I., & Kirschning, A. (2015). Synthesis of new carolacton derivatives and their activity against biofilms of oral bacteria. Organic and Biomolecular Chemistry, 13(20), 5765-5774. https://doi.org/10.1039/c5ob00460h
